1. Translating the results of phase III randomized cancer trials into the language of physician obligation to patients

   • Maurie Markman

   Editor’s Commentary Pages: 243 - 244

2. Literature alert

   Abstract Pages: 246 - 248

3. Web alert

   News Pages: 249 - 249

4. Adjuvant therapy for resected non-small-cell lung cancer: Recent advances, emerging agents, and lingering questions

   • Tara L. Lin
   • Julie R. Brahmer

   OriginalPaper Pages: 251 - 258

5. Estrogen receptor pathways in lung cancer

   • Laura P. Stabile
   • Jill M. Siegfried

   OriginalPaper Pages: 259 - 267

6. Treatment options for small cell lung cancer

   • Todd Wolf
   • Heidi H. Gillenwater

   OriginalPaper Pages: 268 - 271

7. Clinical Trials Report

   • Charles L. Loprinzi

   BriefCommunication Pages: 275 - 276

8. Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer

   • Dawn Hershman
   • Rashmi Narayanan

   OriginalPaper Pages: 277 - 284

9. Management of hot flashes in breast cancer survivors and men with prostate cancer

   • Vered Stearns

   OriginalPaper Pages: 285 - 290

10. Pain management, including intrathecal pumps

    • Thomas J. Smith
    • Craig Swainey
    • Patrick J. Coyne

    OriginalPaper Pages: 291 - 296

11. Management of anemia in patients with cancer

    • David P. Steensma

    OriginalPaper Pages: 297 - 304

12. Clinical Trials Report

    • Shreyaskumar R. Patel

    BriefCommunication Pages: 307 - 308

13. Role of gene expression arrays in sarcomas

    • Keith M. Skubitz
    • Amy P. N. Skubitz

    OriginalPaper Pages: 309 - 314

14. The role and limitations of radiofrequency ablation in treatment of bone and soft tissue tumors

    • Kamran Ahrar

    OriginalPaper Pages: 315 - 320

15. Management of sarcomas of the head and neck

    • Bruce Brockstein

    OriginalPaper Pages: 321 - 327